OXYMETAZOLINE HYDRO

The contract, awarded by the Defense Logistics Agency to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0), is a single-line-item delivery order under basic contract SPE2DX25D9900 for the supply of OXYMETAZOLINE HYDRO, identified by NSN 6505008694177, with a total value of $7.55. The award was issued on July 21, 2026, with delivery required by the same date to the primary address in Morrisville, North Carolina, under FOB Destination terms, meaning the contractor bears all costs and risk until the goods reach the destination. The contractor is certified as a Women-Owned Small Business under NAICS 325412 with a size standard of 1,300 employees, and the procurement is governed by FAR 52.212-4 and FAR 52.212-5, indicating it is for commercial items under a Firm Fixed Price structure. Inspection and acceptance are conducted by the government at the delivery point, and the contractor must ensure all shipments are sent via traceable means, with no use of parcel post, and must mark each package with the contract identifier, CLIN, and a specific traceable code: W51J4X62020013. No detailed packaging, preservation, or labeling standards beyond basic identification are specified, and no military standards such as MIL-STD-129 or MIL-STD-2073 are referenced. Payment is to be processed through the Defense Finance and Accounting Service in Columbus, Ohio, and invoices must be submitted to that address. The contracting officers include Lisa Quinn and Lorinda Ferraiolo, with administrative support from Shairy Cartagena and Catherine Gilbert. The clause 52.222-50 on Combating Trafficking in Persons is incorporated, and the contractor’s small business and WOSB certifications trigger compliance with reporting requirements under FAR 52.219-8 and 52.219-9. The contract contains no options, extensions, or additional line items, and the basis of award is inferred to be Lowest Price Technically Acceptable given the minimal value and lack of documented evaluation factors or technical scoring. The solicitation number SPE2DX-24-R-0001 and award notice SPE2DP26F791